Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2184448

Cc1nc(C)c2ccccc2n1.N

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.61
ALDH1A1 P00352 4/20 0.61
CYP1A2 P05177 2/20 0.61
HPGD P15428 2/20 0.61
HSD17B10 Q99714 2/20 0.61
NUDT1 P36639 1/20 0.61
LMNA P02545 2/20 0.53
HTT P42858 1/20 0.53
MPO P05164 1/20 0.50
RAD52 P43351 1/20 0.50
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PDE10A Q9Y233 1/20 0.44
BACE1 P56817 1/20 0.44
NCF1 P14598 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PRNP P04156 1/20 0.44
TSHR P16473 1/20 0.44
MAPK10 P53779 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14775623 0.98 GPR3 (0.59) GPR3ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL196601 0.98 GPR3 (0.64) GPR3ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL27974035 0.86 ALDH1A1 (0.56) GPR3ALDH1A1CYP1A2HPGDHSD17B10
Formamide SCHEMBL28690144 0.85 HSD17B10 (0.55) GPR3ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL30249662 0.80 GPR3 (0.59) GPR3ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL4681829 0.80 GPR3 (0.59) GPR3ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL1772609 0.78 L3MBTL1 (0.53) GPR3ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL856788 0.77 TDP1 (0.54) GPR3ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL29461212 0.77 TDP1 (0.54) GPR3ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL85621 0.76 GPR3 (1.00) GPR3ALDH1A1CYP1A2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 CN claimed
CN-104363908-A Pyrrolidino heterocycles HOFFMANN LA ROCHE 2015-02-18 CN claimed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
CN-117736207-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-03-22 CN disclosed
CN-115362003-B Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-03-22 CN disclosed
CN-117624063-A Heterocyclic compound and application thereof 中国科学院上海药物研究所 2024-03-01 CN disclosed
CN-112110918-B Spiro substituted pyrimido cyclic compounds, process for their preparation and their use in medicine 劲方医药科技(上海)有限公司 2023-08-22 CN disclosed
WO-2023133217-A1 2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES REMIX THERAPEUTICS INC. (US) 2023-07-13 WO disclosed
WO-2023121429-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF 아주대학교산학협력단 2023-06-29 WO disclosed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 CN disclosed
CN-115362003-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2022-11-18 CN disclosed
CN-111315723-A Extramembranous nucleotide pyrophosphatase-phosphodiesterase 1(ENPP-1) inhibitor and application thereof 艾伯维公司 2020-06-19 CN disclosed
CN-103797024-B Hepatitis c virus inhibitors BRISTOL-MYERS SQUIBB CO. (US) 2016-06-01 CN disclosed
CN-104918941-A Hepatitis c virus inhibitors BRISTOL MYERS SQUIBB CO 2015-09-16 CN disclosed
CN-104693211-A Imidazole derivative as antiviral agent and pharmaceutical application thereof NANJING MINGDE NEW DRUG RES AND DEV CO LTD 2015-06-10 CN disclosed
CN-104363908-A Pyrrolidino heterocycles HOFFMANN LA ROCHE 2015-02-18 CN disclosed
CN-103797024-A Hepatitis c virus inhibitors BRISTOL MYERS SQUIBB CO 2014-05-14 CN disclosed
EP-2342191-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE Mitsubishi Tanabe Pharma Corporation (JP) 2011-07-13 EP disclosed
CN-101779124-A modulation of chemosensory receptors and ligands associated therewith SENOMYX INC 2010-07-14 CN disclosed
WO-2010030027-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-18 WO disclosed